202 related articles for article (PubMed ID: 19064593)
1. Effect of bladder distention on bladder base dose in gynaecological intracavitary high dose rate brachytherapy.
Adli M; Garipagaoglu M; Kocak Z
Br J Radiol; 2009 Mar; 82(975):243-8. PubMed ID: 19064593
[TBL] [Abstract][Full Text] [Related]
2. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
3. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
[TBL] [Abstract][Full Text] [Related]
4. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer.
Pelloski CE; Palmer M; Chronowski GM; Jhingran A; Horton J; Eifel PJ
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):131-7. PubMed ID: 15850913
[TBL] [Abstract][Full Text] [Related]
5. Cone beam CT-based three-dimensional planning in high-dose-rate brachytherapy for cervical cancer.
Al-Halabi H; Portelance L; Duclos M; Reniers B; Bahoric B; Souhami L
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1092-7. PubMed ID: 19879059
[TBL] [Abstract][Full Text] [Related]
6. Comparative assessment of doses to tumor, rectum, and bladder as evaluated by orthogonal radiographs vs. computer enhanced computed tomography-based intracavitary brachytherapy in cervical cancer.
Datta NR; Srivastava A; Maria Das KJ; Gupta A; Rastogi N
Brachytherapy; 2006; 5(4):223-9. PubMed ID: 17118314
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
Beriwal S; Kim H; Heron DE; Selvaraj R
Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
[TBL] [Abstract][Full Text] [Related]
8. Bladder dose estimation during intracavitary brachytherapy for carcinoma of the cervix using a single line source system.
Tan LT; Warren J; Freestone G; Jones B
Br J Radiol; 1996 Oct; 69(826):953-62. PubMed ID: 9038532
[TBL] [Abstract][Full Text] [Related]
9. Additional rectal and sigmoid mucosal points and doses in high dose rate intracavitary brachytherapy for carcinoma cervix: a dosimetric study.
Mahantshetty U; Tiwana MS; Jamema S; Mishra S; Engineer R; Deshpande D; Shrivastava S
J Cancer Res Ther; 2011; 7(3):298-303. PubMed ID: 22044811
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric analysis at ICRU reference points in HDR-brachytherapy of cervical carcinoma.
Eich HT; Haverkamp U; Micke O; Prott FJ; Müller RP
Rontgenpraxis; 2000; 53(2):62-6. PubMed ID: 10994367
[TBL] [Abstract][Full Text] [Related]
11. Maximum and mean bladder dose defined from ultrasonography. Comparison with the ICRU reference in gynaecological brachytherapy.
Barillot I; Horiot JC; Maingon P; Bone-Lepinoy MC; Vaillant D; Feutray S
Radiother Oncol; 1994 Mar; 30(3):231-8. PubMed ID: 8209007
[TBL] [Abstract][Full Text] [Related]
12. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
[TBL] [Abstract][Full Text] [Related]
13. Dosimetry of intracavitary placements for uterine and cervical carcinoma: results of orthogonal film, TLD, and CT-assisted techniques.
Kapp KS; Stuecklschweiger GF; Kapp DS; Hackl AG
Radiother Oncol; 1992 Jul; 24(3):137-46. PubMed ID: 1410567
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer.
Chen SW; Liang JA; Yeh LS; Yang SN; Shiau AC; Lin FJ
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):663-71. PubMed ID: 15380604
[TBL] [Abstract][Full Text] [Related]
15. Use of bladder dose points for assessment of the spatial dose distribution in the posterior bladder wall in cervical cancer brachytherapy and the impact of applicator position.
Nkiwane KS; Pötter R; Fokdal LU; Hoskin P; Pearcey R; Segedin B; Mahantshetty U; Kirisits C
Brachytherapy; 2015; 14(2):252-9. PubMed ID: 25530424
[TBL] [Abstract][Full Text] [Related]
16. [Historical overview and the current practice of intracavitary treatment of cervical and endometrial cancer in the Oncoradiology Center of Budapest].
Sinkó D; Nemeskéri C; Pallinger Á; Weisz C; Naszály A; Landherr L
Magy Onkol; 2015 Jun; 59(2):140-7. PubMed ID: 26035162
[TBL] [Abstract][Full Text] [Related]
17. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy.
Pötter R; Van Limbergen E; Gerstner N; Wambersie A
Radiother Oncol; 2001 Jan; 58(1):11-8. PubMed ID: 11165676
[TBL] [Abstract][Full Text] [Related]
18. Can point doses predict volumetric dose to rectum and bladder: a CT-based planning study in high dose rate intracavitary brachytherapy of cervical carcinoma?
Patil VM; Patel FD; Chakraborty S; Oinam AS; Sharma SC
Br J Radiol; 2011 May; 84(1001):441-8. PubMed ID: 21511749
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric comparison of tandem and Ovoids vs. tandem and ring for intracavitary gynecologic applications.
Levin D; Menhel J; Rabin T; Pfeffer MR; Symon Z
Med Dosim; 2008; 33(4):315-20. PubMed ID: 18973861
[TBL] [Abstract][Full Text] [Related]
20. A comparison of ICRU point doses and volumetric doses of organs at risk (OARs) in brachytherapy for cervical cancer.
Vinod SK; Caldwell K; Lau A; Fowler AR
J Med Imaging Radiat Oncol; 2011 Jun; 55(3):304-10. PubMed ID: 21696566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
